Toxicities and Outcome after CD19-directed Chimeric Antigen Receptor T-cell Therapy for Neurolymphomatosis (S29.010)
Jeremy S. Abramson, Sofia Doubrovinskaia, Philipp Karschnia, Leon D. Kaulen et al.
Journal
Neurology
Topics
CAR-T cell therapy research
article
Toxicities and Outcome after CD19-directed Chimeric Antigen Receptor T-cell Therapy for Neurolymphomatosis (S29.010)
Jeremy S. Abramson, Sofia Doubrovinskaia, Philipp Karschnia, Leon D. Kaulen, Jörg Dietrich, María Martínez-Lage, Matthew J. Frigault, Wolfgang Wick, Ganesh M. Shankar
article en
Abstract
No abstract available for this paper.
Publication Tag
NeurologyVol. 104(7_Supplement_1)
Institutions
Harvard University (US), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Heidelberg University (DE), Massachusetts General Hospital (US), Neurology, Inc (US)